retatrutide autoimmune Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Delivers Bariatric-Level Weight Loss
Description
Clinical trials show approximately 24-29% weight loss with retatrutide versus ~15% with semaglutide and ~21% with tirzepatide

Maintain Open Communication and Provide Support: Establish ongoing communication with your clients through phone calls, emails, or virtual consultations

Alzheimers Disease International

The team at Mind Matters Psychiatry & Weight Loss in Longwood, Florida, specializes in evidence-based medical weight-loss programs, including GLP-1 therapies such as semaglutide and tirzepatide.

K.SuttlesJ.et al (2016)

just notice the pattern
